Cristina Miranda

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol.

Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol.

Journal: BMJ open

Published: April 11, 2025

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Journal: The Journal of clinical investigation

Published: June 20, 2024

Early virological failure with cabotegravir/rilpivirine.

Early virological failure with cabotegravir/rilpivirine.

Journal: The Journal of antimicrobial chemotherapy

Published: February 22, 2024

Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project.

Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project.

Journal: HIV medicine

Published: September 13, 2023

Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders.

Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders.

Journal: Pathogens (Basel, Switzerland)

Published: October 03, 2022

Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution.

Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution.

Journal: The Journal of infectious diseases

Published: July 05, 2022

Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.

Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.

Journal: iScience

Published: June 02, 2022

Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.

Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.

Journal: AIDS (London, England)

Published: November 09, 2021

Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat.

Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat.

Journal: The Journal of antimicrobial chemotherapy

Published: June 30, 2021

Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.

Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.

Journal: The Journal of antimicrobial chemotherapy

Published: July 22, 2020

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).

Journal: Frontiers in immunology

Published: February 13, 2020

Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report.

Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis - a case report.

Journal: BMC nephrology

Published: August 01, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026